SINGAPORE (Reuters) - Indian pharmaceutical company Strides Shasun Ltd has launched a share sale to raise funds up to 15 billion rupees ($225.7 million), IFR reported on Friday, citing a source close to the transaction.
Strides is selling shares at 1,278 rupees apiece in the transaction, which comprises a base deal for 10 billion rupees with an upsize option of 5 billion rupees, IFR, a Thomson Reuters publication, said.
Axis and Jefferies are the bookrunners for the deal, it said.
($1 = 66.4505 Indian rupees)
(Reporting by S. Anuradha; Editing by Gopakumar Warrier)
